Caricamento...

Immune Therapy for Liver Cancers

Hepatocellular carcinoma (HCC) and biliary tract cancers (BTC) display a poor prognosis with 5-year overall survival rates around 15%, all stages taken together. These primary liver malignancies are often diagnosed at advanced stages where therapeutic options are limited. Recently, immune therapy ha...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cancers (Basel)
Autori principali: Hilmi, Marc, Vienot, Angélique, Rousseau, Benoît, Neuzillet, Cindy
Natura: Artigo
Lingua:Inglês
Pubblicazione: MDPI 2019
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7016834/
https://ncbi.nlm.nih.gov/pubmed/31892230
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12010077
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !